Silvercrest Asset Management’s Organon & Co OGN Stock Holding History

Silvercrest Asset Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,489	Closed	-$182K	–	865
2023 Q3	$182K	Buy	10,489 +630	+6%	+$13.1K	﹤0.01%	801
2023 Q2	$205K	Sell	9,859 -508	-5%	-$11K	﹤0.01%	794
2023 Q1	$244K	Sell	10,367 -423	-4%	-$11.4K	﹤0.01%	748
2022 Q4	$301K	Sell	10,790 -1,731	-14%	-$44.3K	﹤0.01%	712
2022 Q3	$293K	Sell	12,521 -1,797	-13%	-$54.3K	﹤0.01%	706
2022 Q2	$483K	Sell	14,318 -2,278	-14%	-$79.8K	﹤0.01%	647
2022 Q1	$580K	Sell	16,596 -42	-0.3%	-$1.44K	﹤0.01%	666
2021 Q4	$507K	Sell	16,638 -1,976	-11%	-$64.4K	﹤0.01%	674
2021 Q3	$611K	Sell	18,614 -17,848	-49%	-$571K	﹤0.01%	644
2021 Q2	$1.1M	Buy	+36,462	New	+$1.2M	0.01%	556

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Silvercrest Asset Management's OGN Position: Q4 2023 in Review

Silvercrest Asset Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 10,489 shares — an estimated $182K sold.

Silvercrest Asset Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.1M in Q2 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Silvercrest Asset Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Silvercrest Asset Management sold 10,489 Organon & Co shares in Q4 2023, an estimated $182K.
Silvercrest Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Silvercrest Asset Management's Organon & Co position peaked at $1.1M in Q2 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Silvercrest Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.